Newsletter
Hypothermia for Severe TBI, RAS Inhibitors After TAVR, OAC-PPI Therapy and UGIB, and more

JAMA Editor’s Summary

Hypothermia for Severe TBI, RAS Inhibitors After TAVR, OAC-PPI Therapy and UGIB, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 04, 2018 issue
December 4, 2018

Hypothermia for Severe TBI, RAS Inhibitors After TAVR, OAC-PPI Therapy and UGIB, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 04, 2018 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
The Happy Nurse: Sustaining the Health of Nurses with Kay Reynoldson